Abstract:Gait is a core motor function and is impaired in numerous neurological diseases, including Parkinson's disease (PD). Treatment changes in PD are frequently driven by gait assessments in the clinic, commonly rated as part of the Movement Disorder Society (MDS) Unified PD Rating Scale (UPDRS) assessment (item 3.10). We proposed and evaluated a novel approach for estimating severity of gait impairment in Parkinson's disease using a computer vision-based methodology. The system we developed can be used to obtain an estimate for a rating to catch potential errors, or to gain an initial rating in the absence of a trained clinician-for example, during remote home assessments. Videos (n=729) were collected as part of routine MDS-UPDRS gait assessments of Parkinson's patients, and a deep learning library was used to extract body key-point coordinates for each frame. Data were recorded at five clinical sites using commercially available mobile phones or tablets, and had an associated severity rating from a trained clinician. Six features were calculated from time-series signals of the extracted key-points. These features characterized key aspects of the movement including speed (step frequency, estimated using a novel Gamma-Poisson Bayesian model), arm swing, postural control and smoothness (or roughness) of movement. An ordinal random forest classification model (with one class for each of the possible ratings) was trained and evaluated using 10-fold cross validation. Step frequency point estimates from the Bayesian model were highly correlated with manually labelled step frequencies of 606 video clips showing patients walking towards or away from the camera (Pearson's r=0.80, p<0.001). Our classifier achieved a balanced accuracy of 50% (chance = 25%). Estimated UPDRS ratings were within one of the clinicians' ratings in 95% of cases. There was a significant correlation between clinician labels and model estimates (Spearman's ρ=0.52, p<0.001). We show how the interpretability of the feature values could be used by clinicians to support their decision-making and provide insight into the model's objective UPDRS rating estimation. The severity of gait impairment in Parkinson's disease can be estimated using a single patient video, recorded using a consumer mobile device and within standard clinical settings; i.e., videos were recorded in various hospital hallways and offices rather than gait laboratories. This approach can support clinicians during routine assessments by providing an objective rating (or second opinion), and has the potential to be used for remote home assessments, which would allow for more frequent monitoring.

Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson's disease

Toward interpretable digital biomarkers of walking and reaching in Parkinson's disease

Functional Connectome Predicting Individual Gait Function and Its Relationship with Molecular Architecture in Parkinson's Disease

Comprehensive blood metabolomics profiling of Parkinson’s disease reveals coordinated alterations in xanthine metabolism

Clinical and device-based predictors of improved experience of activities of daily living after a multidisciplinary inpatient treatment for people with Parkinson's disease: a cohort study

Clinical and device-based predictors of improved experience of activities of daily living after a multidisciplinary inpatient treatment for people with Parkinson’s disease: a cohort study

A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson's Disease

Leveraging the Potential of Digital Technology for Better Individualized Treatment of Parkinson's Disease

Assessing real-world gait with digital technology? Validation, insights and recommendations from the Mobilise-D consortium

Patient perspectives on the use of digital medical devices and health data for AI-driven personalised medicine in Parkinson's Disease

Simplification of Mobility Tests and Data Processing to Increase Applicability of Wearable Sensors as Diagnostic Tools for Parkinson's Disease

Can Gait Features Help in Differentiating Parkinson's Disease Medication States and Severity Levels? A Machine Learning Approach

Wearable multisource quantitative gait analysis of Parkinson's diseases

Gait analysis with wearables predicts conversion to Parkinson disease

Technical validation of real-world monitoring of gait: a multicentric observational study

Monipar: movement data collection tool to monitor motor symptoms in Parkinson's disease using smartwatches and smartphones

WearGait-PD: An Open-Access Wearables Dataset for Gait in Parkinson's Disease and Age-Matched Controls

Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease

Specific Distribution of Digital Gait Biomarkers in Parkinson's Disease Using Body-Worn Sensors and Machine Learning.

The Role of Deep Learning and Gait Analysis in Parkinson's Disease: A Systematic Review

Detection and Assessment of Parkinson's Disease Based on Gait Analysis: A Survey